testosterone undecanoate has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, R; Cui, J; Hu, H; Li, P; Liu, X; Wang, Q; Wei, W | 1 |
Bentz, EK; Bilban, M; Hefler, LA; Horvat, R; Huber, JC; Kaufmann, U; Pils, D; Reinthaller, A; Singer, CF; Tempfer, CB | 1 |
1 trial(s) available for testosterone undecanoate and Breast Cancer
Article | Year |
---|---|
Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals.
Topics: Administration, Oral; Biomarkers, Tumor; Breast; Breast Neoplasms; Carcinoma; Chemotaxis, Leukocyte; Female; Gene Expression; Gene Expression Profiling; Genes, Neoplasm; Gonadal Steroid Hormones; Humans; Injections, Intramuscular; Lynestrenol; Male; Microarray Analysis; Sex Reassignment Procedures; Testosterone; Transsexualism; Validation Studies as Topic | 2010 |
1 other study(ies) available for testosterone undecanoate and Breast Cancer
Article | Year |
---|---|
Antiproliferative effects of anastrozole on MCF-7 human breast cancer cells in vitro are significantly enhanced by combined treatment with testosterone undecanoate.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Nitriles; Receptors, Androgen; Signal Transduction; Testosterone; Triazoles | 2015 |